CISH Inactivated TILs in the Treatment of NSCLC

NCT05566223 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No recruitment

Conditions

Carcinoma, Non-Small-Cell Lung
Metastatic Non Small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer
Squamous Cell Lung Cancer
Adenocarcinoma of Lung
Large Cell Lung Cancer

Interventions

DRUG: Fludarabine
DRUG: Cyclophosphamide
BIOLOGICAL: CISH Inactivated TIL
DRUG: Aldesleukin
DRUG: Pembrolizumab

Sponsor

Intima Bioscience, Inc.